ArticleBreast (Edinburgh, Scotland)2026

Impact of pathologic response and individual prognosis after neoadjuvant treatment in patients with early HER2+ and triple-negative breast cancer.

Chiara Corti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.